Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Medulloblastoma 2Glioblastoma 2Ependymoma 2Breast Neoplasms 2Brain Neoplasms 2Prostatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Diffuse Intrinsic Pontine Glioma 1Breast Neoplasms, Male 1

Interventions

Temozolomide 10Radiotherapy 10Bevacizumab 6Everolimus 5ribociclib 3Radiation 3Panobinostat 3Dasatinib 3Valproic Acid 2TIC10 compound 2Re-Irradiation 2Nivolumab 2Mebendazole 2Irinotecan 2Gemcitabine 2GDC-0084 2Etoposide 2Erlotinib Hydrochloride 2Diphtheria-Tetanus Vaccine 2Cyclophosphamide 2Cilengitide 2Cetuximab 2vandetanib 1tovorafenib 1temsirolimus 1spartalizumab 1sargramostim 1reolysin 1pembrolizumab 1ovex 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Diffuse Intrinsic Pontine Glioma × 1-methyltryptophan × Clear all
NCT04049669 2026-01-08

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

Augusta University

Phase 2 Active not recruiting
130 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡